HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virginia L Stauffer Selected Research

Virginia L Stauffer Research Topics

Disease

25Schizophrenia (Dementia Praecox)
10/2014 - 01/2004
21Migraine Disorders (Migraine)
01/2022 - 01/2018
4Psychotic Disorders (Schizoaffective Disorder)
02/2012 - 11/2010
4Mania (Manias)
06/2004 - 02/2002
3Vomiting
02/2021 - 11/2013
3Pain (Aches)
02/2021 - 01/2020
3Weight Gain
12/2010 - 03/2009
2Headache (Headaches)
05/2021 - 01/2018
2Photophobia (Light Sensitivity)
02/2021 - 06/2019
2Nausea
02/2021 - 06/2019
2Hyperacusis (Phonophobia)
02/2021 - 06/2019
2Epilepsy (Aura)
02/2021 - 01/2018
2Injection Site Reaction
05/2020 - 01/2020
2Pruritus (Itching)
05/2020 - 01/2020
2Psychomotor Agitation (Akathisia)
02/2012 - 09/2010
1Prodromal Symptoms
02/2021
1Prescription Drug Overuse
01/2021
1Erythema
05/2020
1Constipation
01/2020
1Vertigo (Positional Vertigo)
01/2020
1Syndrome (Syndromes)
01/2017
1Major Depressive Disorder (Major Depressive Disorders)
01/2017
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
10/2014
1Metabolic Bone Diseases (Osteopenia)
10/2013
1Hyperprolactinemia
10/2013
1Bone Resorption
10/2013
1Hypogonadism (Hypergonadotropic Hypogonadism)
10/2013
1Substance-Related Disorders (Drug Abuse)
09/2010
1Dyskinesias (Dyskinesia)
01/2010
1Body Weight (Weight, Body)
04/2009
1Bipolar Disorder (Manic Depressive Psychosis)
03/2009
1Weight Loss (Weight Reduction)
03/2009
1Insulin Resistance
05/2007
1Seizures (Absence Seizure)
01/2004
1Treatment-Resistant Schizophrenia
01/2004
1Dementia (Dementias)
07/2003

Drug/Important Bio-Agent (IBA)

20galcanezumabIBA
08/2021 - 01/2018
20Olanzapine (Zyprexa)FDA Link
11/2013 - 02/2002
19Antipsychotic Agents (Antipsychotics)IBA
11/2013 - 01/2003
6Monoclonal AntibodiesIBA
02/2021 - 01/2018
6Calcitonin Gene-Related PeptideIBA
02/2021 - 01/2018
6Risperidone (Risperdal Consta)FDA LinkGeneric
11/2013 - 07/2003
5Aripiprazole (Abilify)FDA Link
11/2013 - 12/2008
4ProlactinIBA
10/2013 - 07/2003
3Quetiapine Fumarate (Seroquel)FDA Link
11/2013 - 06/2007
3Haloperidol (Haldol)FDA LinkGeneric
05/2011 - 06/2007
2pomaglumetad methionilIBA
10/2014 - 11/2013
2Biomarkers (Surrogate Marker)IBA
05/2011 - 01/2010
2Triglycerides (Triacylglycerol)IBA
12/2010 - 01/2010
2ziprasidone (Geodon)FDA Link
12/2010 - 06/2007
1Biological ProductsIBA
05/2020
1alpha- ((5- fluoro- 2- methoxyphenyl)methyl)- alpha- (tetrahydro- 2H- pyran- 4- yl)- 2- morpholinemethanolIBA
01/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2017
1Glutamic Acid (Glutamate)FDA Link
10/2014
1LY 2140023IBA
11/2013
1metabotropic glutamate receptor 2IBA
11/2013
1collagen type I trimeric cross-linked peptideIBA
10/2013
1Testosterone (Sustanon)FDA Link
10/2013
1iloperidoneFDA Link
03/2012
1antineoplaston A10 (A 10)IBA
06/2010
1Uvitex SWN (SWN)IBA
05/2010
1Amantadine (Aman)FDA LinkGeneric
03/2009
1sibutramine (Meridia)FDA Link
03/2009
1CarbohydratesIBA
03/2009
1Nizatidine (Axid)FDA LinkGeneric
03/2009
1Glucose (Dextrose)FDA LinkGeneric
05/2007
1Clozapine (Clozaril)FDA LinkGeneric
01/2004

Therapy/Procedure

10Therapeutics
11/2013 - 02/2002
4Injections
01/2022 - 11/2018
2Subcutaneous Injections
01/2021 - 12/2018
2Aftercare (After-Treatment)
01/2019 - 06/2009
1Withholding Treatment
01/2019
1Drug Therapy (Chemotherapy)
03/2009
1Home Nursing (Nursing, Home)
07/2003